Acropolis Investment Management LLC Has $6.51 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Acropolis Investment Management LLC trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 0.7% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 11,127 shares of the healthcare conglomerate’s stock after selling 74 shares during the quarter. Acropolis Investment Management LLC’s holdings in UnitedHealth Group were worth $6,505,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in the business. L.M. Kohn & Company lifted its stake in shares of UnitedHealth Group by 1.6% in the third quarter. L.M. Kohn & Company now owns 5,037 shares of the healthcare conglomerate’s stock valued at $2,945,000 after buying an additional 81 shares in the last quarter. Caisse DE Depot ET Placement DU Quebec lifted its stake in shares of UnitedHealth Group by 129.7% in the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate’s stock valued at $601,951,000 after buying an additional 581,324 shares in the last quarter. Fred Alger Management LLC lifted its stake in shares of UnitedHealth Group by 91.9% in the third quarter. Fred Alger Management LLC now owns 199,460 shares of the healthcare conglomerate’s stock valued at $116,620,000 after buying an additional 95,503 shares in the last quarter. Captrust Financial Advisors lifted its position in shares of UnitedHealth Group by 0.9% during the third quarter. Captrust Financial Advisors now owns 210,464 shares of the healthcare conglomerate’s stock valued at $123,054,000 after purchasing an additional 1,789 shares in the last quarter. Finally, Kingfisher Capital LLC lifted its position in shares of UnitedHealth Group by 1.2% during the third quarter. Kingfisher Capital LLC now owns 2,923 shares of the healthcare conglomerate’s stock valued at $1,709,000 after purchasing an additional 36 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $610.53 on Friday. The company has a 50 day moving average of $585.43 and a 200 day moving average of $556.08. The stock has a market cap of $561.86 billion, a P/E ratio of 39.77, a P/E/G ratio of 1.79 and a beta of 0.58. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter in the previous year, the company earned $6.56 earnings per share. UnitedHealth Group’s revenue for the quarter was up 9.2% on a year-over-year basis. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be paid a $2.10 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.38%. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on UNH shares. Cantor Fitzgerald raised their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research report on Wednesday, October 16th. Barclays raised their price target on shares of UnitedHealth Group from $603.00 to $655.00 and gave the company an “overweight” rating in a research report on Wednesday. Truist Financial reaffirmed a “buy” rating and issued a $625.00 price objective (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. KeyCorp initiated coverage on shares of UnitedHealth Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective on the stock. Finally, Stephens lowered their price objective on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average target price of $618.26.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.